Resolution of Thrombi in Left Atrial Appendage With Edoxaban

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

May 19, 2019

Primary Completion Date

October 30, 2023

Study Completion Date

August 1, 2024

Conditions
Atrial FibrillationLeft Atrial Appendage Thrombosis
Interventions
DRUG

Edoxaban

Edoxaban will be used for resolution of left atrial appendage thrombi

Trial Locations (12)

21431

Catholic University of Korea, Incheon St. Mary's hospital, Incheon

26426

Wonju Severance Christian Hospital, Wŏnju

41931

Keimyung University Dongsan Medical Center, Daegu

41944

Division of Cardiology, Department of Internal Medicine, Kyungpook National University Hospital, Daegu

42415

Division of Cardiology, Department of Internal Medicine, Yeungnam University Hospital, Daegu

42472

Division of Cardiology, Department of Internal Medicine, Daegu Catholic University Medical Center, Daegu

49241

Pusan National University Hospital, Pusan

02841

Korea University Anam Hospital, Seoul

03080

Seoul National University Hospital, Seoul

03722

Severance Cardiovascular Hospital, Seoul

06351

Seoul Samsung Medical Center, Seoul

07345

Catholic University of Korea Yeouido St. Mary's Hospital, Seoul

All Listed Sponsors
collaborator

Daiichi Sankyo Korea Co., Ltd., a Daiichi Sankyo Company

INDUSTRY

lead

Keimyung University Dongsan Medical Center

OTHER

NCT03840291 - Resolution of Thrombi in Left Atrial Appendage With Edoxaban | Biotech Hunter | Biotech Hunter